A Non-interventional Post Authorisation Safety Study (PASS) of Patients with MoCD Type A Treated with NULIBRY (fosdenopterin)

First published 17/05/2024

Last updated 14/07/2026

EU PAS number:

EUPAS1000000093

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

ni-pass-protocol v1.3_7MAY2024.pdf

English (851.41 KB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

A Non-interventional Post Authorisation Safety Study (PASS) of Patients with MoCD Type A Treated with NULIBRY (fosdenopterin)

Secondary tabs

Share this page